| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMCI | Common Stock | Sale | -$960K | -52.4K | -0.91% | $18.34 | 5.7M | Nov 22, 2021 | Direct | F1, F2 |
| transaction | TMCI | Common Stock | Sale | -$12.3K | -646 | -0.01% | $19.11 | 5.7M | Nov 22, 2021 | Direct | F1, F3 |
| transaction | TMCI | Common Stock | Sale | -$926K | -53.3K | -0.93% | $17.37 | 5.65M | Nov 23, 2021 | Direct | F1, F4 |
| transaction | TMCI | Common Stock | Sale | -$49.1K | -2.73K | -0.05% | $18.00 | 5.64M | Nov 23, 2021 | Direct | F1, F5 |
| transaction | TMCI | Common Stock | Sale | -$455K | -25.7K | -0.46% | $17.66 | 5.62M | Nov 24, 2021 | Direct | F1, F6 |
| transaction | TMCI | Common Stock | Sale | -$545K | -30.3K | -0.54% | $18.00 | 5.59M | Nov 24, 2021 | Direct | F1, F7 |
| holding | TMCI | Common Stock | 1.61M | Nov 22, 2021 | By Wife | F8 | |||||
| holding | TMCI | Common Stock | 1.47M | Nov 22, 2021 | By Wife as cotrustee of the JTT Irrevocable Trust dated September 30, 2020 | F8 | |||||
| holding | TMCI | Common Stock | 1.84M | Nov 22, 2021 | As Trustee of the Tracy W. Treace Irrevocable Trust dated September 25, 2020 | F9 | |||||
| holding | TMCI | Common Stock | 409K | Nov 22, 2021 | As Co-Trustee of the John R. Treace Irrevocable Trust dated July 29, 2021 | F9 |
| Id | Content |
|---|---|
| F1 | Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. |
| F2 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.01 to $19.00 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.02 to $19.54 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.14 to $17.66 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.21 to $18.47 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.94 to $17.93 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.94 to $18.09 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F8 | The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee. |
| F9 | The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee. |